The Lymphoma and Myeloma team at RPCI looks at the whole picture when assessing a patient’s prognosis, including pathology, radiology, staging, symptoms and laboratory values, to predict whether a patient will do well with standard therapy or need more aggressive treatment—from the start.
The best chance of curing a patient is choosing the best and optimal therapy as the first treatment, rather than trying to salvage with second or subsequent therapies later on. —Myron Czuczman, MD, Chief, Lymphoma/Myeloma Service and Head, Lymphoma Translational Research Laboratory, Department of Immunology.
The RPCI Edge
The challenge is to choose the appropriate combination of therapies for the specific patient—a choice based on sound, logical evidence. As a comprehensive cancer center that’s intimately involved in the research and development of these new therapies—and determining how best to optimize their benefits—RPCI is uniquely equipped to meet that challenge for each patient.
The aim of understanding each patient’s disease is a concerted effort involving surgeons (who do the biopsies) and experienced hematopathologists, was work with colleagues from Cytogenetics, the Laboratory of Molecular Diagnostics, and the Department of Flow Cytometry, with invaluable input from the Diagnostic Radiology and Nuclear Medicine departments.
The lymphoma and myeloma team at our Institute includes physicians, scientists, hematopathologists, radiologists, radiation oncologists, fellows, nurse practitioners, physician assistants, pharmacists, social workers, clinical nurses, research coordinators and psychologists working as a cohesive group of professionals dedicated to providing compassionate and high-quality care for our patients and to advancing our understanding and treatment of hematologic malignancies.
Clinical Pharmacy Support
RPCI’s clinical pharmacy specialists work closely with physicians, nurse practitioners and physician assistants in both inpatient and ambulatory care settings to provide optimal pharmaceutical care to patients.
Our clinical pharmacists are dedicated to the Lymphoma/Myeloma Service, monitoring all therapeutic drugs, provide recommendations for growth factor support, antiemetics and pain control, offer medication reviews and patient discharge counseling, and staff a 24-hour hotline to offer drug information, interaction checks, dosing recommendations for renal and hepatic insufficiencies, and more.